Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical Trial.

Circulation. Genomic and Precision Medicine
Chengxian GuoGuoping Yang

Abstract

Warfarin is an effective treatment for thromboembolic disease but has a narrow therapeutic index; optimal anticoagulation dosage can differ tremendously among individuals. We aimed to evaluate whether genotype-guided warfarin dosing is superior to routine clinical dosing for the outcomes of interest in Chinese patients. We conducted a multicenter, randomized, single-blind, parallel-controlled trial from September 2014 to April 2017 in 15 hospitals in China. Eligible patients were ≥18 years of age, with atrial fibrillation or deep vein thrombosis without previous treatment of warfarin or a bleeding disorder. Nine follow-up visits were performed during the 12-week study period. The primary outcome measure was the percentage of time in the therapeutic range of the international normalized ratio during the first 12 weeks after starting warfarin therapy. A total of 660 participants were enrolled and randomly assigned to a genotype-guided dosing group or a control group under standard dosing. The genotype-guided dosing group had a significantly higher percentage of time in the therapeutic range than the control group (58.8% versus 53.2% [95% CI of group difference, 1.1-10.2]; P=0.01). The genotype-guided dosing group also achieved th...Continue Reading

Associated Clinical Trials

References

Sep 20, 2006·The Pharmacogenomics Journal·M Wadelius, M Pirmohamed
Nov 9, 2007·Circulation·Jeffrey L AndersonUNKNOWN Couma-Gen Investigators
Feb 21, 2009·The New England Journal of Medicine·UNKNOWN International Warfarin Pharmacogenetics ConsortiumJ A Johnson
Mar 6, 2010·Blood·Nita A LimdiUNKNOWN International Warfarin Pharmacogenetics Consortium
Jun 30, 2010·Journal of Thrombosis and Thrombolysis·Joyce H S YouGregory Cheng
Jan 5, 2011·Journal of Clinical Epidemiology·Gordon GuyattHolger J Schünemann
May 10, 2013·Journal of Human Genetics·Ming Ta Michael Lee, Teri E Klein
Nov 21, 2013·The New England Journal of Medicine·Stephen E KimmelUNKNOWN COAG Investigators
Nov 21, 2013·The New England Journal of Medicine·Munir PirmohamedUNKNOWN EU-PACT Group
May 31, 2015·Blood·Nita A LimdiT Mark Beasley
Nov 20, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Xiaojuan YanJianqiang Ding
Jul 7, 2016·Circulation. Cardiovascular Quality and Outcomes·Zhi-Zun WangChang-Sheng Ma
Aug 16, 2016·Lancet·Jeff S HealeyUNKNOWN RE-LY Atrial Fibrillation Registry and Cohort Study Investigators
Jan 24, 2017·Pharmacogenomics·Ming-Shien WenMing Ta Michael Lee

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2022 Meta ULC. All rights reserved